Medpace (MEDP) Just Soared 50%—Is This the Most Underrated Biotech Play of 2025?
Medpace Holdings Inc. (NASDAQ:MEDP) is a leading global contract research organization (CRO) that partners with biopharmaceutical, biotechnology, and…
Browsing Tag